The clinical records of 20 patients with histologically proved, nonobstructive "active chronic pyelonephritis" as their sole renal lesion were selected for study. Six had chronic or recurrent ...

THE clinical diagnosis of pyelonephritis is frequently overlooked, and the disparity between the clinical and post-mortem findings in this infection has been emphasized repeatedly. 1–4 The failure of ...

Background and aims: Urinary tract infections (UTIs) are relatively common infections in children. Findings on nuclear renal scans suggest that the vast majority of infants and young children with ...

Acute pyelonephritis is a common and potentially serious infection of the renal parenchyma and pelvis that affects patients worldwide, with a higher incidence in women and older adults. Typical ...

WALTHAM, Mass.--(BUSINESS WIRE)--Entasis Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, reported positive topline ...

"The five factors with the highest odds of developing APN included obstructive and reflux uropathy, presentation to an acute care facility, urinary retention, history of UTI, and renal comorbidities.

RARITAN, N.J., Sept. 17Â -- The U.S. Food and Drug Administration (FDA) has approved use of the five-day, once-daily regimen of LEVAQUIN(R) (levofloxacin) 750 mg I.V. and oral, for the treatment of ...

CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― ...